Interise Trust approves Rs 1,800 Cr Commercial Papers
Interise Trust announced that its Investment and Finance Committee approved the issuance of Commercial Papers up to Rs 1,800 Crores in one or more tranches on May 22, 2026. The decision was communicated to the stock exchanges and relevant trustees.

*this image is generated using AI for illustrative purposes only.
Interise Trust has announced the outcome of its Investment and Finance Committee meeting held on May 22, 2026. The committee has approved the issuance of Commercial Papers in one or more tranches up to an aggregate amount not exceeding Rs. 1,800 Crores.
Meeting Outcome
The decision was taken during the meeting convened by Interise Investment Managers Private Limited, acting as the Investment Manager to the Trust. The approval authorizes the Trust to raise funds through the debt instrument to meet its financial requirements.
Key Details
| Parameter | Details |
|---|---|
| Meeting Body | Investment and Finance Committee of the Board of Directors |
| Meeting Date | May 22, 2026 |
| Approval | Issuance of Commercial Papers |
| Aggregate Amount | Up to Rs. 1,800 Crores |
| Structure | One or more tranches |
Regulatory Compliance
The intimation regarding the meeting outcome was submitted to BSE Limited and the National Stock Exchange of India Limited. The filing was signed by Amit Shah, Chief Compliance Officer and Vice President – Company Secretary, on May 22, 2026.
Copies of the intimation were addressed to the Trustee, IDBI Trusteeship Services Limited, the Debenture Trustee, Axis Trustee Services Limited, and the Issuer and Paying Agent, ICICI Bank Limited.
How will Interise Trust deploy the Rs. 1,800 Crores raised through Commercial Papers, and which infrastructure projects or assets are likely to benefit from this capital infusion?
What impact could this significant debt issuance have on Interise Trust's debt-to-equity ratio and its overall credit rating outlook?
Given current interest rate conditions, at what yield are these Commercial Papers likely to be priced, and how competitive will they be compared to similar instruments in the market?

































